جست‌وجوی استاد و پژوهشگر

Ronald L. Schnaarمشاهده پروفایل

استاد

• Glycobiology
• Neuroscience
• Cell Surface Molecular Recognition
• +۵ مورد دیگر

Ronald L. Schnaar, PhD, is the John Jacob Abel Professor of Pharmacology and Interim Director of the Department of Pharmacology and Molecular Sciences at Johns Hopkins University School of Medicine. With appointments in both the Department of Pharmacology and the Department of Neuroscience, he is a leading expert in glycobiology whose research bridges neuroscience and immunology. His research focuses on cell surface molecular recognition, particularly the roles of gangliosides and Siglec receptors in neural cell-cell interactions, myelin maintenance, and axon regeneration. His laboratory has made seminal discoveries showing that gangliosides serve as ligands for myelin-associated glycoprotein (MAG), which has important implications for understanding nerve repair mechanisms. More recently, his work has expanded to explore how Siglec receptors and their glycan ligands regulate inflammatory processes in the airways and brain. Analysis of his recent publications reveals a strong interdisciplinary approach combining chemical biology, neuroscience, and immunology to investigate glycan-mediated interactions. His work demonstrates how basic research on cell surface glycans translates into potential therapeutic applications for neurodegenerative diseases and inflammatory conditions. John Jacob Abel Professor of Pharmacology Dr. Schnaar has mentored over 20 PhD students who have gone on to successful careers in academia, industry, and government. His laboratory, currently comprising research associates, graduate students, and postdoctoral fellows, is supported by multiple NIH grants focusing on glycan biology in neural and immune contexts. The lab has developed innovative chemical biology tools for studying ganglioside interactions in live cells. The Schnaar laboratory maintains active collaborations with researchers across Johns Hopkins and internationally, with particular emphasis on translating basic discoveries about glycan recognition into potential therapeutic approaches for neurological and inflammatory diseases.

Stephen Carpenterمشاهده پروفایل

استادیار

• Infectious Disease Immunology
• Tuberculosis Research
• Vaccine Development
• +۳ مورد دیگر

Stephen Carpenter, MD, PhD, is an Assistant Professor in the Departments of Medicine (Division of Infectious Diseases & HIV Medicine) and Pathology at Case Western Reserve University School of Medicine. His research focuses on understanding T cell and macrophage interactions in Mycobacterium tuberculosis (Mtb) infections, with the goal of developing novel TB vaccines. Previously, he held roles as an Attending Physician at Brigham and Women’s Hospital/Dana-Farber Cancer Institute and Director of Early Clinical Development at Regeneron Pharmaceuticals. His lab employs cutting-edge techniques like single-cell transcriptomics and TCR sequencing to study immune responses in latent TB infection. Education: MD and PhD from University of Massachusetts Medical School. Key career milestones include postdoctoral training under Dr. Sam Behar, residency at NYU School of Medicine, and fellowship at Harvard Medical School/Massachusetts General Hospital. Research Interests: Vaccine-elicited T cell responses, Mtb-host interactions, macrophage biology, and translational immunology. His lab’s work bridges basic science and clinical applications, aiming to translate findings into therapeutic strategies against chronic infections. Lab Members: Includes post-doctoral scholars (Robert Schauner, Vlad Stetsenko), research assistants (Dan Gail, Nancy Nagy, Scott Reba), and PhD candidates (Vinicius Suzart, Avinaash Kaur Sandhu). The lab is located at BRB1040, Biomedical Research Building, Cleveland, OH.

• Molecular Entomology
• Insect Resistance Mechanisms
• Biological Pest Control
• +۷ مورد دیگر

Patricia Hernandez Martinez is an Assistant Professor in the Department of Genetics at the Faculty of Biological Sciences, University of Valencia. She is affiliated with the Universitat Institute of Biotechnology and Biomedicine (BIOTECMED) and a member of the research group 'CPB Biotechnological Pest Control'. Her work focuses on the molecular mechanisms of insect resistance to Bacillus thuringiensis (Bt) toxins. Her research interests lie at the intersection of molecular entomology, toxicology, and agricultural biotechnology. She investigates how Bt insecticidal proteins such as Cry and Vip3 interact with midgut receptors in pest insects, how resistance evolves, and the functional characterization of these toxins. Her work combines biochemical assays, molecular biology, and in vivo testing to understand toxin-receptor dynamics. The recent publication record shows a consistent focus on Bt toxin binding mechanisms, resistance development in key agricultural pests (e.g., Spodoptera, Ostrinia, Heliothis), and structural-functional analysis of Cry and Vip3 proteins. Themes include receptor identification, cross-resistance, binding competition, and the impact of mutations or gene expression changes on toxin susceptibility. Patricia Hernandez Martinez has not received any publicly listed scientific awards in the provided text. She actively contributes to research through her role in the CPB Biotechnological Pest Control group at BIOTECMED. While no specific grants or student advisement details are mentioned, her extensive publication list suggests active research funding and mentorship within her team. She conducts her research within the CPB Biotechnological Pest Control group at the Universitat Institute of Biotechnology and Biomedicine (BIOTECMED), a multidisciplinary research environment focused on developing sustainable pest control solutions using biotechnological approaches.

Jeremy Nathansمشاهده پروفایل

استاد

• Developmental Neuroscience
• Neurobiology of Disease
• Molecular Genetics
• +۱۲ مورد دیگر

Jeremy Nathans is a Professor in the Department of Molecular Biology and Genetics at the Johns Hopkins University School of Medicine. His research spans developmental neuroscience and the neurobiology of disease, with a focus on Frizzled receptors and their role in mammalian development. His research interests include neural and vascular development, Wnt signaling, retinal biology, and the molecular basis of sensory systems. The Nathans laboratory employs gene manipulation in mice, cell culture models, and biochemical reconstitution to investigate molecular events in development and disease. Key areas include axon guidance, neural tube closure, retinal vascularization, and planar cell polarity. The trends in his recent publications highlight a strong focus on neurovascular development, particularly through Wnt and Norrin signaling pathways. His work integrates single-cell genomics, structural biology, and mouse genetics to understand barrier formation, limb development, and disease models. Themes include Frizzled receptor function, endothelial cell biology, and transcriptional regulation in neural and vascular tissues. Dr. Nathans has mentored numerous researchers and contributed to major advances in visual pigment genetics and retinal disease mechanisms. His laboratory has developed innovative technologies for genetic manipulation and visualization of cell populations in the mouse. He has secured significant research funding to support his work in developmental signaling and disease modeling. He leads an active research lab focused on the molecular mechanisms of development, particularly in the visual system and central nervous system. The lab utilizes advanced techniques including genetically directed cell labeling, single-cell RNA sequencing, and structural analysis to dissect signaling pathways in vivo.

John G. Purdyمشاهده پروفایل

دانشیار

• Virology
• Metabolomics
• Lipid Metabolism
• +۳ مورد دیگر

John G. Purdy is an Associate Professor of Immunobiology and Cancer Biology at the University of Arizona, where he has been a faculty member since October 2015. He is also a Faculty Fellow at the BIO5 Institute, an interdisciplinary research center focused on solving complex problems in health, agriculture, and environment. Dr. Purdy earned his undergraduate degree from Pacific University and completed his Ph.D. at Penn State University College of Medicine. He then pursued postdoctoral training in metabolomics at the Lewis-Sigler Institute for Integrative Genomics, Princeton University, working with Drs. Joshua Rabinowitz and Thomas Shenk. Dr. Purdy's research focuses on understanding how viruses, particularly human cytomegalovirus (HCMV), remodel host cell metabolic and lipid environments to facilitate their replication. His work aims to identify key cellular and viral targets for the development of novel antiviral therapies. The Purdy Lab employs biochemical, molecular, and genetic approaches to analyze metabolomic and lipidomic dynamics during viral infection, with a particular emphasis on fatty acid elongation and very long-chain fatty acid synthesis. Analysis of Dr. Purdy's recent publications reveals a consistent focus on virus-host metabolic interactions, particularly how HCMV manipulates lipid metabolism. His work spans multiple disciplines including virology, metabolomics, lipidomics, and cell biology, with applications to understanding viral pathogenesis and developing antiviral strategies. A recurring theme is the role of very-long-chain fatty acids in viral replication, with significant contributions to understanding how viruses rewire host metabolic pathways. R01 Award (2021) - Metabolite mediated signaling in cell-to-cell spread of HCMV R01 Award (2021) - HCMV reprogramming of lipid metabolism Dr. Purdy leads the Purdy Lab at the University of Arizona, which includes postdoctoral researchers, laboratory coordinators, graduate students, and undergraduate volunteers. Current lab members include Dr. Rebekah Mokry (Postdoctoral Research Associate), Nathan Schmidt (Laboratory Coordinator), and several graduate and undergraduate students. The lab has successfully mentored multiple students to completion of their degrees, including Dr. Yuecheng Xi who completed her PhD in 2021. Dr. Purdy was promoted to Associate Professor with Tenure in July 2022, reflecting his significant contributions to research and education.

• Cell Biology
• Molecular Imaging
• Host-Pathogen Interactions
• +۳ مورد دیگر

Kai Sandvold Beckwith is an Associate Professor at the Department of Biomedical Engineering, Faculty of Natural Sciences, Norwegian University of Science and Technology (NTNU). His research focuses on developing advanced microscopy techniques to study cellular processes, including mechanobiology , host-pathogen interactions , and genome organization . He previously worked as a Researcher at CEMIR (2023-2024), Postdoctoral Coordinator at Ellenberg Group (EMBL Heidelberg, 2019-2023), and Postdoc at Flo Group (NTNU, 2016-2019). He obtained his PhD in Biophysics (2015) and MSc in Bionanotechnology (2011) from NTNU. Research Interests include: Nanoscale DNA organization mechanisms Quantitative imaging of chromatin dynamics Pathogen-induced inflammasome activation Development of high-resolution microscopy tools Host-pathogen interaction at molecular level Genome architecture in cancer development Scientific Contributions reveal expertise in super-resolution microscopy, correlative imaging, and pathogen-host cell dynamics. His 2025 Cell and Journal of Cell Biology studies on DNA organization and loop extruders demonstrate cutting-edge work in chromosome structure analysis. Earlier publications span nanofabrication, tuberculosis infection mechanisms, and TLR8 immunology. Advising includes supervising doctoral and master's theses with students like Ragnhild Sofie Ragnhildstveit Sætra, Marit Bugge, and Anne Marstad. His work connects to collaborative teams at NTNU's CEMIR and EMBL Heidelberg, with frequent conference presentations at venues like EMBO and Frontiers in Immunology events.

• Neuroscience
• Neurology
• Ion Channels
• +۷ مورد دیگر

Stephen Waxman is the Bridget Flaherty Professor of Neurology, Neuroscience, and Pharmacology at Yale School of Medicine. He serves as Director of the Center for Neuroscience and Regeneration Research and previously chaired the Department of Neurology from 1986 to 2009. He has held faculty positions at Harvard, MIT, and Stanford prior to joining Yale. MD, Albert Einstein College of Medicine (1972) PhD, Albert Einstein College of Medicine (1970) Residency, Boston City Hospital (1975) Clinical Fellowship, Harvard Medical School (1975) Postdoctoral Fellowship, MIT (1975) Dr. Waxman’s research focuses on the molecular basis of nervous system disorders, particularly ion channel function in multiple sclerosis, spinal cord injury, and neuropathic pain. His pioneering work has elucidated how sodium channel plasticity contributes to recovery in demyelinated axons and has identified specific ion channel mutations underlying hereditary pain syndromes. He integrates molecular biology, genetics, electrophysiology, and computational modeling to develop novel therapies. His recent publications highlight advancements in automated electrophysiology, pharmacogenomics, and the discovery of new analgesic targets such as Nav1.8 and TRPM8. His work on non-addictive pain medications is currently being tested in Phase II clinical trials, and he has identified ion channels involved in osteoarthritis and pain resilience. Notable scientific awards include: Member, National Academy of Medicine Julius Axelrod Prize, Society for Neuroscience Mitchell Max Award, American Academy of Neurology Soriano Award, American Neurological Association British Physiological Society Annual Prize Dystel Prize, American Academy of Neurology Dr. Waxman has trained numerous scientists who now lead research teams worldwide. He has served on editorial boards of leading journals including Annals of Neurology , Brain , Journal of Physiology , and Nature Reviews Neurology , and is Editor of The Neuroscientist . His laboratory is actively involved in the PROPANE Neuropathy Genomics Project, CRS Injury and Repair, and the International Pain Genomics Consortium. He leads the Waxman Lab at the Center for Neuroscience and Regeneration Research, which employs state-of-the-art techniques in molecular imaging, stem cell models, and high-throughput electrophysiology to study nerve excitability and develop targeted therapies for neurological disorders.

• Molecular Biology
• Cellular Biology
• Developmental Biology
• +۱۲ مورد دیگر

John Carlson is the Eugene Higgins Professor of Molecular, Cellular, and Developmental Biology at Yale University, where he is a full Professor in the Department of Molecular, Cellular, and Developmental Biology (MCDB) within the Yale School of Medicine. He also holds affiliations with the Interdepartmental Neuroscience Program, Kavli Institute for Neuroscience, Wu Tsai Institute, and the Biological & Biomedical Sciences Graduate Program (BBS). Education: Ph.D. in Biochemistry, Stanford University (1982) A.B. in Biochemistry, Harvard University (1977) John Carlson’s research centers on the molecular and neural mechanisms of chemoreception. His lab investigates how Drosophila and disease-transmitting insects such as mosquitoes detect odors, tastes, and pheromones. His groundbreaking work includes the discovery of the first insect odor and taste receptors and the elucidation of the logic underlying sensory coding in olfactory and gustatory systems. His current research extends to understanding how these mechanisms influence behavior in vectors of global disease. His recent publications (2022–2025) highlight advances in insect chemoreception, including the structural basis of sugar detection, the function of ionotropic receptors in mate recognition, and the role of taste in mosquito biting behavior. These works reflect a strong trend toward integrating molecular genetics, structural biology, and behavioral analysis to decode sensory systems. Scientific Awards and Honors: Elected Member, National Academy of Sciences Elected Member, American Academy of Arts and Sciences Guggenheim Fellow Fellow, American Association for the Advancement of Science (AAAS) Genetics Society of America Medal Kornberg-Berg Lifetime Achievement Award (Stanford) Max Mozell Award for Outstanding Achievement in the Chemical Senses Yale College Dylan Hixon Prize for Teaching Excellence Yale College Byrnes/Sewall Teaching Prize Yale Postdoctoral Mentoring Prize John Carlson is a dedicated mentor and educator. Seventeen of his PhD students have won dissertation awards, and he has received multiple honors for teaching and mentoring. He leads an active research lab that fosters collaboration and interdisciplinary inquiry. His lab has frequent co-authors including Gaëlle J. S. Talross, Yichen Luo, Hany Dweck, and Lisa Baik, indicating a strong team-based research environment focused on sensory biology and vector behavior.

Colin Fishwickمشاهده پروفایل

استاد

• Medicinal Chemistry
• Synthetic Methods
• Chemical Biology
• +۱۲ مورد دیگر

Professor Colin Fishwick is a faculty member at the University of Leeds, where he serves as Professor of Medicinal Chemistry and Head of the School of Chemistry. He is also an Honorary Visiting Professor at the University of Bradford’s Institute of Cancer Therapeutics and at the University of Sheffield. His work bridges computational drug design and synthetic chemistry to address major global health challenges. Research Interests: His research focuses on medicinal chemistry, synthetic methods, chemical biology, drug design, and molecular modelling. He pioneers computational tools like SPROUT for fragment-based design and applies them to discover novel ligands for challenging targets. His work spans antimicrobial resistance (particularly against ESKAPE pathogens), neglected tropical diseases (malaria, toxoplasmosis), cardiovascular repair, and diabetes therapeutics. He integrates cryo-EM, computational biology, and synthetic chemistry to develop selective small molecules and chemical probes. Publication Trends: His recent publications reflect a strong emphasis on combating antibiotic resistance through dual-targeting strategies and novel enzyme inhibitors. He also advances anti-parasitic drug development, particularly DHODH and mPPase inhibitors, and explores insulin signalling restoration for diabetes. His work increasingly incorporates solid-form property prediction for improved drug bioavailability. Scientific Awards: No specific awards mentioned in the text. Advising and Grants: He leads a research group in Chemical Biology and Medicinal Chemistry and welcomes PhD students. He collaborates with Medicines for Malaria Venture (MMV) and the Leeds Institute of Cardiovascular and Molecular Medicine (LICAMM), indicating involvement in externally funded projects. While specific grants are not listed, his international collaborations and project descriptions imply sustained funding. Labs and Teams: He leads the research group focused on computational and synthetic approaches to drug discovery within the School of Chemistry. He is affiliated with the Astbury Centre and collaborates across disciplines, including parasitology, cardiovascular medicine, and structural biology.

Katie Simmonsمشاهده پروفایل

مدرس

• Structural Pharmacology
• Medicinal Chemistry
• Chemical Biology
• +۷ مورد دیگر

Dr. Katie Simmons is a Lecturer in Structural Pharmacology at the School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds. Her research integrates computational and experimental approaches to identify bioactive molecules for early-stage drug discovery, targeting diseases such as Type 2 Diabetes, epilepsy, and cardiometabolic disorders. Research Interests: Medicinal Chemistry and Ligand Design Molecular Modelling and In Silico Screening Chemical Biology and Fragment-Based Discovery Molecular Biology and Assay Development Targeting Integrins, Ion Channels, and Receptor Hybrids Her work emphasizes the development of therapeutic leads through collaborations within the University of Leeds and with industrial partners. Key projects include RGD-mimetics for insulin sensitization, fluorine-containing inhibitors for cardiovascular protection, potassium channel blockers for epilepsy, and modulators of IR-IGF1R hybrids. Research Trends in Publications: Her recent scholarly output centers on early-stage drug discovery, combining computational prediction with synthetic chemistry and biophysical validation. Articles reflect a strong focus on structural pharmacology, targeting protein-protein interactions, receptor modulation, and fragment-based screening, particularly using NMR and in silico methods. Scientific Contributions: Lead discovery for cardiometabolic diseases Development of novel therapeutics for rare epilepsies Innovation in fluorine-based NMR screening Tool compound generation for hybrid receptor studies Advising and Research Support: Dr. Simmons leads an active research group focused on structural pharmacology and drug discovery. She mentors students and researchers in interdisciplinary projects combining computational modelling, synthetic chemistry, and molecular biology. Her work is supported by academic collaborations and aims to translate findings into industrial partnerships for further development. Laboratory and Research Environment: Based in Garstang 6.44F at the University of Leeds, her lab utilizes a range of techniques including molecular modelling, small molecule synthesis, assay development, and biophysical methods such as NMR. The group collaborates widely across institutions to advance therapeutic leads.

Anthony Holtmaatمشاهده پروفایل

استاد

• Synaptic Plasticity
• Neuroscience
• Structural Plasticity
• +۱۳ مورد دیگر

Anthony Holtmaat is a Professor and Group Leader in the Faculty of Medicine at the University of Geneva. He leads a research laboratory focused on synaptic plasticity and cortical network dynamics in the adult brain, utilizing in vivo imaging and molecular techniques in transgenic mouse models. Research Interests: His work centers on understanding how synaptic connectivity changes in response to experience and learning. Using longitudinal in vivo two-photon microscopy, his lab investigates dendritic spine and axonal bouton dynamics, synapse formation and elimination, and the molecular stability of synaptic proteins. His research integrates structural and functional analyses to explore how neural circuits adapt during sensory processing, memory formation, and aging. Recent Research Trends: His latest publications reveal a strong focus on thalamocortical feedback mechanisms, sensory-evoked cortical plasticity, and the regulation of neuronal excitability through metabotropic glutamate receptors. A landmark study generated a comprehensive atlas of synapse protein lifetimes across the mouse brain, linking synaptic stability to brain development, aging, and neurodevelopmental disorders such as autism and schizophrenia. Scientific Awards: No specific awards mentioned in the provided text. Advising and Grants: He mentors a diverse team of postdoctoral researchers, PhD candidates, and technicians, indicating active supervision and training. His research is supported by competitive funding, as evidenced by publications in high-impact journals and collaborations with international teams. The mention of NIH funding (R01 MH060919) in a co-authored paper suggests involvement in externally funded research projects. Laboratory and Team: His lab at the CMU (Centre Médical Universitaire) in Geneva includes多名 researchers such as Tanika Bawa, I-Wen Chen, and Ronan Chereau, working on various aspects of synaptic and circuit plasticity. The team employs cutting-edge techniques including two-photon calcium imaging, optogenetics, viral tracing, and advanced data analysis to dissect neural circuit function.

• Cancer Biology
• Signal Transduction
• Biophysics
• +۴ مورد دیگر

Dr. Daryl Klein is an Associate Professor of Pharmacology at Yale School of Medicine, affiliated with the Yale Cancer Biology Institute, Yale Cancer Center, and the Program in Translational Biomedicine. He holds a MD and PhD from the University of Pennsylvania (2009, 2008) and a BA in Biology (1999). His research focuses on molecular mechanisms of cancer metastasis, particularly signal integration across biological membranes. He investigates how signaling 'codes' in receptor structures drive disease progression and designs synthetic interventions to override these pathways. His interdisciplinary work combines biophysics, virology, and high-throughput screening to target metastatic pathways and enhance immune responses. Recent research highlights include structural studies of Isthmin-1 (2025), interactions between RTKs and GPCRs in Drosophila (2025), and GABAA receptor signaling in ERK activation (2024). He leads a lab at Yale West Campus Advanced Biosciences Center and has secured grants like a $10.5M NIH award for membrane protein research (2023). Collaborations with experts like Mark Lemmon and Steve Stayrook drive his work. Current projects aim to develop CAR-T cell therapies for neuroblastoma (ALK inhibition synergy) and structural biology of receptor systems. His lab hosts a vibrant research environment with over 20 publications in high-impact journals like Nature Communications and Molecular Cell. Future directions include synthetic biology approaches to reprogram cancer signaling circuits and translating findings into clinical therapeutics.

Frederick A Pereiraمشاهده پروفایل

دانشیار

• Auditory Development
• Aging
• Cancer Prevention
• +۶ مورد دیگر

Frederick A Pereira is an Associate Professor at Baylor College of Medicine , affiliated with the Huffington Center on Aging , Dan L Duncan Comprehensive Cancer Center , and the Graduate School of Biomedical Sciences where he serves as Director of Graduate and Postbaccalaureate Development. His research bridges molecular biology, neuroscience, and audiology. Departments: Molecular and Cellular Biology, Otolaryngology–Head and Neck Surgery Research Interests focus on: Signaling pathways in auditory development, aging, and cancer prevention Circadian rhythms and their role in inner ear and brain function Orphan nuclear receptors (e.g., NR2F1/COUP-TFI) in cellular regeneration Mechanisms of outer hair cell motor proteins (prestin) and lipidemia-related hearing deficits Publication Trends show interdisciplinary work in neuroscience , genetics , and biochemistry , with studies on gene deletion models, cholesterol modulation of auditory proteins, and computational analyses of transcriptional networks. His 2019 study on Nr2f1 knockout mice links auditory and neurological disorders. Affiliations include: Huffington Center on Aging (Houston, TX) Dan L Duncan Comprehensive Cancer Center (Baylor College of Medicine)

• Medical Biochemistry
• Cell Biology
• Mucin Research
• +۳ مورد دیگر

Sara K. Lindén is a Professor at the Department of Medical Biochemistry and Cell Biology, University of Gothenburg. Her research spans multiple biological systems, focusing on mucin biochemistry, host-pathogen interactions, and glycosylation patterns across human respiratory and gastrointestinal systems, as well as fish mucosal surfaces. Key methodologies include mass spectrometry, histochemical staining, and in vitro infection models. University of Gothenburg, Department of Medical Biochemistry and Cell Biology Research Interests: Mucin structure and function in host defense Glycosylation patterns in human and fish mucosal tissues Pathogen binding mechanisms (Helicobacter pylori, Aeromonas salmonicida, Brachyspira hyodysenteriae) Impact of smoking and inflammation on airway mucin composition Quorum sensing inhibition by host mucins Article Trends: Recent work emphasizes comparative mucin biology across species (human, pig, fish), with applications in infectious disease prevention, COPD pathology, and aquaculture health management. Studies integrate glycomics, proteomics, and functional assays to elucidate molecular interactions. Collaborations: Active in interdisciplinary research involving immunology, microbiology, and veterinary science. Collaborators include teams studying respiratory diseases (COPD), fish pathogens (Aeromonas, Moraxella), and porcine dysentery.

Kerstin Skovgaardمشاهده پروفایل

عضو هیئت علمی

• Antiviral Immunology
• Zoonotic Influenza
• Translational Research
• +۹ مورد دیگر

Kerstin Skovgaard is a Senior Researcher at the Department of Biotechnology and Biomedicine , Technical University of Denmark . Her work focuses on antiviral immunology with emphasis on zoonotic influenza viruses and metabolic syndrome's impact on infection severity . She develops translational animal models for innate immune research in respiratory infections and post-traumatic conditions . Research Interests Antiviral Immunology of influenza A viruses and PEDV Metabolic Syndrome and obesity-related immunity Translational models for respiratory diseases and gut-brain axis miRNA profiling in equine osteoarthritis and porcine infections Immunomodulatory diets with algae and probiotics Biomarker discovery through proteomics and RT-qPCR Scientific Contributions include 202+ publications across influenza , gut immunity , and joint inflammation . Her recent 15 articles demonstrate expertise in porcine models for human diseases , with emphasis on innate immune responses , miRNA dynamics , and metabolic-immune interactions . Supervision includes PhD students : J. Pina Agullet B. L. Henriksen C. J. M. Polhaus H. A. Laybourn C. López-Figueroa Methodologies encompass microfluidic qPCR , RNA-Seq , and advanced in vitro systems . Her research supports UN Sustainable Development Goals through cost-efficient diagnostics and therapeutic development .